Search
for
Sort by
Research 26
- Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- Monocyclic Aromatic Compounds
- Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Debatable Topics in PCOS Patients
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- Novel drugs of United States Food and Drug Administration approved in 2024
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Advances in dermatology research: A comprehensive literature review
- Induction of Cell Proliferation and Cell Death in Human Follicle Dermal Papilla Cells by Zinc Chloride
- A Case-controlled Comparative Hospital-based Study on the Clinical, Biochemical, Hormonal, and Gynecological Parameters in Polycystic Ovary Syndrome
- Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- ORLISTAT
- Hair follicle immune privilege and its collapse in alopecia areata
- Spray-Dried Rosuvastatin Nanoparticles for Promoting Hair Growth
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions